Health tech investment shows signs of recovery in 2024: SVB
Posted:
Funding in the first eight months of the year has already exceeded pre-pandemic levels, according to Silicon Valley Bank. But high valuations recorded in 2021 are still affecting the market.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us